Pathstone Family Office’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-13,424
Closed -$8.88K – 1197
2022
Q4
$8.88K Buy
+13,424
New +$39.1K ﹤0.01% 1268
2019
Q2
– Sell
-1,136
Closed -$5K – 626
2019
Q1
$5K Buy
+1,136
New +$5.22K ﹤0.01% 579
2017
Q3
– Sell
-6,486
Closed -$36K – 171
2017
Q2
$36K Buy
+6,486
New +$37K 0.02% 224
2014
Q4
– Sell
-3,420
Closed -$22K – 108
2014
Q3
$22K Buy
3,420
+1,420
+71% +$10K 0.07% 117
2014
Q2
$14K Hold
2,000
– – 0.04% 78
2014
Q1
$15K Buy
+2,000
New +$14K 0.04% 78

Other funds holding ABEV

Pathstone Family Office's ABEV Position: Q1 2023 in Review

Pathstone Family Office sold out of Ambev (ABEV) in Q1 2023, closing a stake of 13,424 shares — an estimated $8.88K sold.

Pathstone Family Office first reported a position in ABEV in Q1 2014 and held it in 6 quarters. The position peaked at $36K in Q2 2017. 307 funds tracked by Wall St. Rank hold ABEV as of Q1 2023.

  • Pathstone Family Office reported no remaining Ambev position as of Q1 2023 after selling out during the quarter.
  • Pathstone Family Office sold 13,424 Ambev shares in Q1 2023, an estimated $8.88K.
  • Pathstone Family Office first reported a position in Ambev in Q1 2014 and held it in 6 quarters.
  • Pathstone Family Office's Ambev position peaked at $36K in Q2 2017.
  • 307 funds tracked by Wall St. Rank held Ambev as of Q1 2023.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.